Find out more about this
Gesmer Updegrove has represented more than 132 standards consortia and open source foundations, including:
View Full Client List
Useful Links

Communications Center Press Center Sitemap

Tools

Text Size:
Default  Large

RSS Feeds

Bookmark and Share

Standard Setting Organizations
and Standards List

Cancer Cytogenomics Microarray Consortium (CCMC) (now the Cancer Genomics Consortium (CGC))

Overview: The Cancer Cytogenomics Microarray Consortium (CCMC) is a not-for-profit organization formed in 2009 by a group of clinical cytogeneticists, molecular pathologists, and molecular geneticists who are interested in applying microarray technologies to cancer diagnosis and cancer research. Now known as the Cancer Genomics Consortium (CGC), the mission of the consortium is to promote communication and collaboration among cancer cytogenomics laboratories. CGC goals are to: establish platform-neutral and cancer specific microarray designs for diagnostic purposes; share cancer microarray data between participating institutions for education purposes; create a public cancer array database; and carry out multicenter cancer genome translational research. Collaboration amongst the different laboratories and researchers will not only provide validation for the microarray design(s) but ultimately provide more comprehensive molecular information and more accurate interpretation to better serve cancer patients and further cancer research. The CGC has grown to include more than 300 members from over 150 organizations in the U.S., Canada, and abroad.

Specifications: Not available

IPR Policy: Not available

Current Status: Active

Last Updated: November 5, 2013


» Back to Complete List